By taking part in a clinical trial at UAB, you can play a vital role in UAB's internationally renowned research enterprise.

Trials currently available at UAB are listed below; click the tags to refine the list.

addiction adolescents adults aging bioenergetic health and health behavior black blood pressure brain and spinal cord health cancer caregiving children chronic illness covid19 dental health diabetes driving and pedestrian safety exercise nutrition and weight loss eye health gastroenterology and hepatology genetics and genomics healthy heart health hiv aids infectious diseases and immunology kidney health lgbtq lung health men mental health and psychiatry neurology orthopaedics physical medicine rehabilitation and pain rheumatology sexual health sleep health urology urogynecology gynecology and obstetrics white women

February 03, 2023

Have you ever had a heart attack or stroke? Do you have poor circulation?

font size decrease font size increase font size
Print
Email

The University of Alabama at Birmingham (UAB), in collaboration with Novo Nordisk, is conducting a 3-year research study to see if CagriSema, an investigational weekly medicine being studied for the treatment of obesity is also safe for the heart and blood vessels.

We are doing this study to see if CagriSema (Cagrilintide/semaglutide), a new medicine intended for the treatment of obesity, is safe for use in people living with obesity and cardiovascular disease. The study will also include some people with type 2 diabetes and/or chronic kidney disease.

You may qualify to participate if::

You have had a stroke, a heart attack (myocardial infarction), or have poor circulation (peripheral
arterial disease)
You are 55 years of age or older
You are living with obesity (BMI ≥ 30 kg/m2 )
You can have type 2 diabetes and/or chronic kidney disease
You are able to attend regular clinic visits and receive phone calls over
a period of 3 years

Want to know more about the REDEFINE 3 study?
Call the study team at (205) 996-4015 or via email ccnrn@uab.edu

Published in Clinical Trials

back to top

To submit a trial for inclusion in this list, edit an existing listing or request removal of an existing listing, click the buttons below.

Submit a Clinical Trials listing

Request an edit to a listing

Request listing removal

You can also join ResearchMatch, a multi-institution project that pairs volunteers with researchers seeking study participants.

International Students

Faculty

Employees

Media

The University of Alabama at Birmingham

1720 2nd Ave South

Birmingham, AL 35294

Main Switchboard: (205) 934-4011

Hearing Impaired/TDD: (205) 934-4642

Contact UAB
|
|
A-Z Site Index
|
Privacy
|
Terms of Use
|

UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.